Concepedia

Jens‐Kerim Ergüden

JE

Statistics

Publications

6

Citations

527

H-Index

6

Active since

1999

Affiliations

Bayer (Germany)(Current)

Jens‐Kerim Ergüden is an author at Bayer (Germany) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

1999–2018

6

Publications

6

Discovery of BAY 94‐8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases

Lars Bärfacker, Alexander Kühl, Alexander Hillisch et al. · ChemMedChem · 2012 · 264 citations

, , +14

A New Tandem Route to Angular Tetraquinanes. Synthesis of the Waihoensene Ring System

Jens‐Kerim Ergüden, Harold W. Moore · Organic Letters · 1999 · 80 citations

, , +13

Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT<sub>2</sub>) receptor

Frank Wunder, Hanna Tinel, R. Kast et al. · British Journal of Pharmacology · 2010 · 76 citations · Full text

, , +13

Discovery of Molidustat (BAY 85‐3934): A Small‐Molecule Oral HIF‐Prolyl Hydroxylase (HIF‐PH) Inhibitor for the Treatment of Renal Anemia

Hartmut Beck, Mario Jeske, Kai Thede et al. · ChemMedChem · 2018 · 76 citations · Full text

, , +14

Novel, selective indole-based ECE inhibitors: Lead optimization via solid-phase and classical synthesis

Michael Brands, Jens‐Kerim Ergüden, Kentaro Hashimoto et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 21 citations · Full text

, , +14

1–5 of 6